|
Merck initiates first clinical trial of TLR7 and 8 inhibitor as a potential treatment for severe symptoms of COVID-19 infection
|
03 July 2020 |
|
Merck donates one billionth praziquantel tablet
|
30 January 2020 |
|
Merck pioneers new effort to see MS from the inside out
|
30 May 2019 |
|
Merck to collaborate with GenScript to accelerate cell and gene therapy industrialization in China
|
19 March 2019 |
|
Merck announces collaboration with Iktos for generative artificial intelligence (AI) technology
|
14 March 2019 |
|
Merck to expand US biopharmaceutical R&D facility to advance innovative clinical pipeline
|
06 February 2019 |
|
Merck Granted U.S. Patent for novel combination of Artificial Intelligence and Blockchain Technology
|
30 January 2019 |
|
Merck and Tencent announce collaboration on intelligent digital healthcare services in China
|
24 January 2019 |
|
Merck welcomes ten new startups to its Innovation Center
|
16 January 2019 |
|
Merck assigns Chimeric Antigen Receptor T-cell (CAR-T) rights to Intrexon
|
20 December 2018 |
|
Syntropy to unlock the value of scientific data in fight to end cancer
|
20 November 2018 |
|
Merck and Pfizer provide update on avelumab in platinum-resistant/refractory ovarian cancer
|
19 November 2018 |
|
Up to 10-years of follow-up data reaffirm safety profile of Mavenclad (cladribine tablets)
|
10 October 2018 |
|
The Merck Accelerator Program 2019
|
20 September 2018 |
|
Merck awarded Australian CRISPR nickase patent for foundational genome-editing technology
|
15 August 2018 |
|
Merck launches online platform fertility.com
|
03 July 2018 |
|
Merck partners with Medisafe to help improve medication adherence for cardiometabolic patients
|
28 March 2018 |
|
Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel
|
20 February 2018 |
|
Merck is celebrating its anniversary by conducting 350 charitable activities in around 60 countries
|
12 February 2018 |
|
Merck celebrates its 350th anniversary
|
05 February 2018 |